Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the EBITDA margin high or low?
The EBITDA margin of 24.35% is in line with its 5-year average of 24.57%, near the low end of its 5-year range (21.98%–31.74%).
2.31% above its 12-month average of 23.80%.
Reported quarterly EBITDA margin; no daily interpolation.
EBITDA MARGIN
24.35%
EBITDA MARGIN AVG TTM
23.80%
EBITDA MARGIN AVG 3Y
24.05%
EBITDA MARGIN AVG 5Y
24.57%
EBITDA MARGIN AVG 10Y
24.03%
EBITDA MARGIN AVG 15Y
23.12%
EBITDA MARGIN AVG 20Y
23.63%
CURRENT VS TTM AVG
+2.31%
CURRENT VS 3Y AVG
+1.24%
CURRENT VS 5Y AVG
-0.91%
CURRENT VS 10Y AVG
+1.32%
CURRENT VS 15Y AVG
+5.30%
CURRENT VS 20Y AVG
+3.05%
Abbott Laboratories
Market Cap
$182.80B
EBITDA Margin
24.35%
TTM Avg
23.80%
3Y Avg
24.05%
5Y Avg
24.57%
Market Cap
$181.10B
EBITDA Margin
49.12%
TTM Avg
32.26%
3Y Avg
34.27%
5Y Avg
33.90%
Market Cap
$144.00B
EBITDA Margin
30.87%
TTM Avg
31.21%
3Y Avg
32.47%
5Y Avg
31.98%
Market Cap
$224.97B
EBITDA Margin
24.44%
TTM Avg
24.78%
3Y Avg
25.35%
5Y Avg
27.67%
Market Cap
$132.32B
EBITDA Margin
41.14%
TTM Avg
20.45%
3Y Avg
32.86%
5Y Avg
36.27%
Market Cap
$131.69B
EBITDA Margin
36.80%
TTM Avg
38.33%
3Y Avg
39.88%
5Y Avg
39.69%
| NAME | MARKET CAP | EBITDA MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Abbott Laboratories (ABT) | $182.80B | 24.35% | 23.80% | 24.05% | 24.57% |
| Gilead Sciences, Inc. (GILD)vs › | $181.10B | 49.12% | 32.26% | 34.27% | 33.90% |
| Novo Nordisk A/S (NVO)vs › | $198.67B | 48.42% | 49.59% | 48.46% | 47.82% |
| Pfizer Inc. (PFE)vs › | $158.96B | 32.51% | 34.72% | 32.84% | 32.73% |
| Amgen Inc. (AMGN)vs › | $210.69B | 43.12% | 40.78% | 43.34% | 44.32% |
| Danaher Corporation (DHR)vs › | $144.00B | 30.87% | 31.21% | 32.47% | 31.98% |
| Thermo Fisher Scientific Inc. (TMO)vs › | $224.97B | 24.44% | 24.78% | 25.35% | 27.67% |
| Vertex Pharmaceuticals Incorporated (VRTX)vs › | $132.32B | 41.14% | 20.45% | 32.86% | 36.27% |
| Bristol-Myers Squibb Company (BMY)vs › | $131.69B | 36.80% | 38.33% | 39.88% | 39.69% |
| Intuitive Surgical, Inc. (ISRG)vs › | $123.99B | 35.99% | 34.83% | 32.83% | 33.22% |
Gross Margin
56.8%
EBITDA Margin
24.4%
Operating Margin
17.0%
Net Margin
11.7%
Formula: EBITDA Margin = (EBITDA / Revenue) × 100
Why EBITDA Margin matters:
EBITDA Margin = EBITDA / Revenue
EBITDA margin measures operating profitability before interest, taxes, depreciation, and amortization as a percentage of revenue.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EBITDA MARGIN |
|---|---|
| 2026-06-30 | 22.19% |
| 2026-03-31 | 23.04% |
| 2025-12-31 | 23.33% |
| 2025-09-30 | 25.05% |
| 2025-06-30 | 25.39% |
| 2025-03-31 | 23.60% |
| 2024-12-31 | 25.49% |
| 2024-09-30 | 24.63% |
| 2024-06-30 | 24.01% |
| 2024-03-31 | 21.98% |
| 2023-12-31 | 26.14% |
| 2023-09-30 | 24.67% |
| 2023-06-30 | 23.16% |
| 2023-03-31 | 22.63% |
| 2022-12-31 | 22.28% |
| 2022-09-30 | 24.19% |
| 2022-06-30 | 28.03% |
| 2022-03-31 | 31.17% |
| 2021-12-31 | 29.04% |
| 2021-09-30 | 31.74% |
| 2021-06-30 | 28.09% |
| 2021-03-31 | 29.33% |
| 2020-12-31 | 30.65% |
| 2020-09-30 | 25.57% |
| 2020-06-30 | 20.02% |
| 2020-03-31 | 20.80% |
| 2019-12-31 | 25.99% |
| 2019-09-30 | 24.22% |
| 2019-06-30 | 24.33% |
| 2019-03-31 | 20.07% |
| 2018-12-31 | 24.97% |
| 2018-09-30 | 24.33% |
| 2018-06-30 | 23.14% |
| 2018-03-31 | 20.61% |
| 2017-12-31 | 20.79% |
| 2017-09-30 | 24.32% |
| 2017-06-30 | 15.61% |
| 2017-03-31 | 11.18% |
| 2016-12-31 | 24.26% |
| 2016-09-30 | 23.73% |
| 2016-06-30 | 21.81% |
| 2016-03-31 | 17.83% |
| 2015-12-31 | 22.76% |
| 2015-09-30 | 21.28% |
| 2015-06-30 | 20.91% |
| 2015-03-31 | 20.03% |
| 2014-12-31 | 22.12% |
| 2014-09-30 | 21.28% |
| 2014-06-30 | 19.40% |
| 2014-03-31 | 14.55% |
| 2013-12-31 | 20.91% |
| 2013-09-30 | 16.93% |
| 2013-06-30 | 19.52% |
| 2013-03-31 | 19.26% |
| 2012-12-31 | 27.72% |
| 2012-09-30 | 10.95% |
| 2012-06-30 | 12.80% |
| 2012-03-31 | 13.24% |
| 2011-12-31 | 26.32% |
| 2011-09-30 | 14.60% |
| 2011-06-30 | 26.88% |
| 2011-03-31 | 22.64% |
| 2010-12-31 | 25.48% |
| 2010-09-30 | 21.42% |
| 2010-06-30 | 25.85% |
| 2010-03-31 | 26.42% |
| 2009-12-31 | 27.43% |
| 2009-09-30 | 28.10% |
| 2009-06-30 | 29.46% |
| 2009-03-31 | 22.70% |
| 2008-12-31 | 27.24% |
| 2008-09-30 | 25.28% |
| 2008-06-30 | 25.60% |
| 2008-03-31 | 23.64% |
| 2007-12-31 | 27.71% |
| 2007-09-30 | 22.43% |
| 2007-06-30 | 25.46% |
| 2007-03-31 | 26.09% |
| 2006-12-31 | 2.53% |
| 2006-09-30 | 19.21% |
| 2006-06-30 | 17.02% |
| 2006-03-31 | 27.72% |
| 2005-12-31 | 27.09% |
| 2005-09-30 | 21.81% |
| 2005-06-30 | 25.85% |
| 2005-03-31 | 27.51% |
| 2004-12-31 | 25.87% |
| 2004-09-30 | 28.52% |
| 2004-06-30 | 24.45% |
| 2004-03-31 | 23.76% |
| 2003-12-31 | 26.71% |
| 2003-09-30 | 21.84% |
| 2003-06-30 | 10.14% |
| 2003-03-31 | 28.23% |
| 2002-12-31 | 24.27% |
| 2002-09-30 | 27.75% |
